Xiamen Comfort Science&Technology Group Co., Ltd (002614.SZ)
Xiamen, CN
Established in Xiamen, China, in 1996, the company initially known as Xiamen Comfort Science&Technology Group Co., Ltd rebranded to Ogawa Smart Healthcare Technology Group Co., Ltd in May 2017. This enterprise is dedicated to the research, development, manufacturing, and worldwide distribution of a diverse range of health and wellness products. Its extensive offerings include advanced massage solutions like chairs and other devices, environmental control equipment such as humidifiers, air purifiers, and fresh air systems, and a variety of home medical apparatus. This latter category encompasses blood pressure monitors, oximeters, laser hair removal devices, sports bracelets, and other personal health gadgets. These products are marketed predominantly under a portfolio of well-recognized brand names, including OGAWA, FUJI, FUJIMEDIC, COZZIA, MEDISANA, EASEWELL, ihoco, SHUSIJIA, and ETRO.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.18% | -1.92% | -11.23% | -19.63% | -22.41% | -23.26% | -17.86% | -28.44% | -65.05% | -49.64% | -44.89% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 1 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Leisure: +7.6%+5.3% Q1'26: +11.2% (vs Q1'25)
-
EPS growth Leisure: +13.2%-80.0% Q1'26: -3,766.7% (vs Q1'25)
-
FCF margin FCF growth · Leisure: +30.4%-6.0% Q1'26: 0.0% (vs Q1'25)
-
EBIT margin Leisure: +11.0%+1.8% Q1'26: -4.9% (vs Q1'25)
-
ROIC Leisure: +6.9%+1.6% Q1'26: -5.9% (vs Q1'25)
-
Share dilution Leisure: +0.0%-4.5% ★ Q1'26: -9.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Leisure: -0.39×1.49× ★ Q1'26: -2.11× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.83B
est: 3.25B (-12.9%)
|
3.45B
est: 3.16B (+9.2%)
|
4.29B
est: 4.46B (-3.7%)
|
5.45B
est: 5.41B (+0.7%)
|
5.28B
est: 5.31B (-0.7%)
|
7.06B
est: 6.67B (+5.9%)
|
8.29B
est.
|
7.93B
est: 6.85B (+15.7%)
|
6.02B
est: 4.94B (+22.0%)
|
5.03B
est: 4.94B (+1.9%)
|
4.83B
est: 5.00B (-3.2%)
|
5.09B
est: 5.34B (-4.8%)
|
5.53B
5.53B – 5.53B
+3.5% YoY
|
5.96B
5.96B – 5.96B
+7.8% YoY
|
6.35B
6.35B – 6.35B
+6.6% YoY
|
| EBITDA |
290.18M
est: 321.09M (-9.6%)
|
392.08M
est: 312.39M (+25.5%)
|
485.89M
est: 440.87M (+10.2%)
|
628.78M
est: 534.52M (+17.6%)
|
473.02M
est: 525.07M (-9.9%)
|
639.22M
est: 659.29M (-3.0%)
|
819.42M
est.
|
729.89M
est: 676.82M (+7.8%)
|
384.84M
est: 488.01M (-21.1%)
|
359.27M
est: 488.01M (-26.4%)
|
302.92M
est: 357.54M (-15.3%)
|
344.99M
est: 382.28M (-9.8%)
|
395.52M
395.52M – 395.52M
+3.5% YoY
|
426.51M
426.51M – 426.51M
+7.8% YoY
|
454.71M
454.71M – 454.71M
+6.6% YoY
|
| EBIT |
227.17M
est: 169.98M (+33.6%)
|
325.94M
est: 165.37M (+97.1%)
|
413.76M
est: 233.38M (+77.3%)
|
543.91M
est: 282.96M (+92.2%)
|
384.92M
est: 277.96M (+38.5%)
|
528.10M
est: 349.01M (+51.3%)
|
433.78M
est.
|
581.41M
est: 358.29M (+62.3%)
|
230.39M
est: 258.34M (-10.8%)
|
211.24M
est: 258.34M (-18.2%)
|
143.08M
est: 200.78M (-28.7%)
|
90.47M
est: 214.68M (-57.9%)
|
222.11M
222.11M – 222.11M
+3.5% YoY
|
239.52M
239.52M – 239.52M
+7.8% YoY
|
255.35M
255.35M – 255.35M
+6.6% YoY
|
| Net Income |
180.55M
est: 192.72M (-6.3%)
|
251.03M
est: 237.04M (+5.9%)
|
345.18M
est: 388.64M (-11.2%)
|
439.12M
est: 528.90M (-17.0%)
|
288.98M
est: 366.16M (-21.1%)
|
439.28M
est: 485.64M (-9.5%)
|
456.09M
est.
|
458.36M
est: 234.47M (+95.5%)
|
102.02M
est: 173.44M (-41.2%)
|
103.20M
est: 173.44M (-40.5%)
|
64.24M
est: 135.02M (-52.4%)
|
12.27M
est: 92.06M (-86.7%)
|
36.82M
36.82M – 36.82M
-60.0% YoY
|
55.24M
55.24M – 55.24M
+50.0% YoY
|
79.78M
79.78M – 79.78M
+44.4% YoY
|
| SGA |
791.61M
est: 443.15M (+78.6%)
|
981.65M
est: 431.15M (+127.7%)
|
1.07B
est: 608.46M (+75.2%)
|
1.36B
est: 737.72M (+84.2%)
|
1.41B
est: 724.67M (+94.4%)
|
1.50B
est: 909.91M (+64.4%)
|
1.13B
est.
|
1.64B
est: 934.10M (+75.3%)
|
1.50B
est: 673.52M (+122.8%)
|
1.43B
est: 673.52M (+112.7%)
|
1.41B
est: 1.15B (+23.3%)
|
585.33M
est: 1.23B (-52.3%)
|
1.27B
1.27B – 1.27B
+3.5% YoY
|
1.37B
1.37B – 1.37B
+7.8% YoY
|
1.46B
1.46B – 1.46B
+6.6% YoY
|
| EPS |
0.33
est: 0.30 (+10.0%)
|
0.46
est: 0.37 (+24.7%)
|
0.63
est: 0.61 (+4.1%)
|
0.79
est: 0.82 (-4.0%)
|
0.52
est: 0.57 (-8.8%)
|
0.77
est: 0.76 (+1.9%)
|
0.71
est.
|
0.74
est: 0.37 (+102.7%)
|
0.16
est: 0.27 (-40.7%)
|
0.17
est: 0.27 (-37.0%)
|
0.10
est: 0.22 (-54.5%)
|
0.02
est: 0.15 (-86.7%)
|
0.06
0.06 – 0.06
-60.0% YoY
|
0.09
0.09 – 0.09
+50.0% YoY
|
0.13
0.13 – 0.13
+44.4% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 2/5 | 4/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 2/5 | 4/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard FTSE Emerging Markets All Cap Index ETF VEE.TO | 0.00% | 8.3K | 0.26% |
| 2 | Vanguard FTSE Emerging Markets Shares ETF VGE.AX | 0.00% | 3.7K | 0.48% |
| 3 | Vanguard FTSE Emerging Markets ETF VWO | 0.00% | 408.3K | 0.06% |
| 4 | Vanguard FTSE Global All Cap ex Canada Index ETF VXC.TO | 0.00% | 656.15 | 0.22% |
| 5 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 2.0K | 0.22% |
| 6 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 1.1K | 0.22% |
| 7 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 467.93 | 0.22% |
| 8 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 54.08 | 0.22% |
| 9 | Vanguard Retirement Income ETF Portfolio VRIF.TO | 0.00% | 17.77 | 0.31% |
| 10 | Vanguard Conservative Income ETF Portfolio VCIP.TO | 0.00% | 8.46 | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jianhan Zou | Non-Independent Chairman of the Board of Directors & GM | — | male |
| Jing Liao | Accounting Supervisor | — | — |
| Qiao qiao Li | Deputy GM & Secretary of the Board | — | female |
| Shumei Chen | GM of Purchasing Center, Deputy GM & Non-Independent Director | — | female |
| Wei Biao Su | Chief Financial Officer | — | male |
| Wu Ling Li | Non-Independent Vice Chairman of the Board of Directors & Executive Deputy GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002614.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
